Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Combining PRP with Procapil is more effective for hair loss treatment than PRP alone.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Companies agreed to stop making false health claims about their products.

New treatments for hair-pulling disorder focus on personalized approaches and combining therapies for better results.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

PDRN from salmon may slow skin aging by improving skin quality and reducing inflammation.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

The authors agree that standardizing how PRP methods are reported could help compare results, but note that the link between PRP's contents and hair growth is unclear, and recommend avoiding split-scalp designs in future trials.

Toluene lowers body temperature through different mechanisms depending on the concentration.

Mutations in the TSPEAR gene cause a new form of ectodermal dysplasia affecting hair and tooth development.

Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.

Combining PRP with other treatments can improve hair loss outcomes.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

TH07 treatment is promising for hair growth, with higher satisfaction in males.

The ingredients may help prevent hair loss and aging by boosting hair growth signals and reducing stress and hormone effects.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

New drugs like N-acetylcysteine and dronabinol show promise for treating hair-pulling disorder.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Topical melatonin may reduce skin aging by inhibiting certain cellular pathways.

Topical tacrolimus is effective and safe for treating alopecia areata.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.